PixarBio Corporation Builds Regulatory Team Adding Steven Chartier, As Vice President Of Regulatory Affairs, To Lead Non-Opiate, Non-Addictive Pain Treatment Through The U.S. FDA And European Regulatory Bodies

CAMBRIDGE, Mass.--(BUSINESS WIRE)--PixarBio Corporation announced today the appointment of Steven Chartier as V.P. of Regulatory Affairs. He will report to Frank Reynolds, the company’s Chief Executive Officer. Steve is another important piece to the company’s growing infrastructure, in maintaining momentum toward multiple FDA approvals of non-opiate and non-addictive pain treatments in early 2018.